ES543652A0 - Procedimiento de obtencion de derivados 1,4-dihidropiridini-cos - Google Patents
Procedimiento de obtencion de derivados 1,4-dihidropiridini-cosInfo
- Publication number
- ES543652A0 ES543652A0 ES543652A ES543652A ES543652A0 ES 543652 A0 ES543652 A0 ES 543652A0 ES 543652 A ES543652 A ES 543652A ES 543652 A ES543652 A ES 543652A ES 543652 A0 ES543652 A0 ES 543652A0
- Authority
- ES
- Spain
- Prior art keywords
- dihidropiridini
- cos
- procedure
- obtaining derivatives
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH685882 | 1982-11-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES543652A0 true ES543652A0 (es) | 1986-01-16 |
| ES8604147A1 ES8604147A1 (es) | 1986-01-16 |
Family
ID=4316137
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES527776A Expired ES8706633A1 (es) | 1982-11-24 | 1983-11-24 | Procedimiento de preparacion de derivados de 1,4-dihidropiridinas. |
| ES543655A Expired ES8603700A1 (es) | 1982-11-24 | 1985-05-30 | Metodo de preparar compuestos 1,4-dihidropiridinicos |
| ES543654A Expired ES8603699A1 (es) | 1982-11-24 | 1985-05-30 | Metodo de obtener derivados de 1,4-dihidropiridinas |
| ES543652A Expired ES8604147A1 (es) | 1982-11-24 | 1985-05-30 | Procedimiento de obtencion de derivados 1,4-dihidropiridini-cos |
| ES543653A Expired ES8703139A1 (es) | 1982-11-24 | 1985-05-30 | Procedimiento de preparar derivados de 1,4-dihidropiridinas |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES527776A Expired ES8706633A1 (es) | 1982-11-24 | 1983-11-24 | Procedimiento de preparacion de derivados de 1,4-dihidropiridinas. |
| ES543655A Expired ES8603700A1 (es) | 1982-11-24 | 1985-05-30 | Metodo de preparar compuestos 1,4-dihidropiridinicos |
| ES543654A Expired ES8603699A1 (es) | 1982-11-24 | 1985-05-30 | Metodo de obtener derivados de 1,4-dihidropiridinas |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES543653A Expired ES8703139A1 (es) | 1982-11-24 | 1985-05-30 | Procedimiento de preparar derivados de 1,4-dihidropiridinas |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US4656181A (es) |
| EP (1) | EP0126094B1 (es) |
| JP (1) | JPS60500255A (es) |
| CA (1) | CA1256872A (es) |
| DE (1) | DE3381680D1 (es) |
| ES (5) | ES8706633A1 (es) |
| IT (1) | IT1167269B (es) |
| WO (1) | WO1984002132A1 (es) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4603135A (en) * | 1983-10-17 | 1986-07-29 | Takeda Chemical Industries, Ltd. | Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates |
| JPS60120861A (ja) * | 1983-12-02 | 1985-06-28 | Otsuka Pharmaceut Co Ltd | ジヒドロピリジン誘導体 |
| US5137889A (en) * | 1983-12-02 | 1992-08-11 | Otsuka Pharmaceutical Co., Ltd. | Dihydropyridine derivatives and process for preparing the same |
| IE57810B1 (en) * | 1984-03-27 | 1993-04-21 | Delagrange Lab | 1,4-dihydropyridine derivatives,their preparation and their use |
| GB2162513B (en) * | 1984-06-25 | 1988-01-20 | Toyama Chemical Co Ltd | Dihydropyridine derivatives |
| JPS6147477A (ja) * | 1984-08-14 | 1986-03-07 | Kowa Co | 新規１，４−ジヒドロピリジン−３，５−ジカルボン酸エステル誘導体 |
| FI853478L (fi) * | 1984-09-14 | 1986-03-15 | Ciba Geigy Ag | Foerfarande foer framstaellning av fenylalkylfoereningar. |
| US4975440A (en) * | 1984-09-28 | 1990-12-04 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Optically-active 1,4-dihydropyridine |
| GB8428552D0 (en) * | 1984-11-12 | 1984-12-19 | Sandoz Ltd | Organic compounds |
| JPH0676405B2 (ja) * | 1986-06-13 | 1994-09-28 | 日清製粉株式会社 | １，４―ジヒドロピリジン誘導体およびそれを含有する医薬組成物 |
| US4757071A (en) * | 1984-12-14 | 1988-07-12 | Nisshin Flour Milling Co., Ltd. | 1,4-dihydropyridine derivatives, and pharmaceutical compositions containing same, useful for treating cardiovascular diseases |
| IL77843A (en) * | 1985-02-11 | 1989-07-31 | Syntex Inc | Dihydropyridine derivatives,process and novel intermediates for their preparation and pharmaceutical compositions containing them |
| JPS61227567A (ja) * | 1985-04-01 | 1986-10-09 | Eisai Co Ltd | １，４−ジヒドロピリジン誘導体 |
| EP0222702A3 (de) * | 1985-11-06 | 1988-01-07 | Ciba-Geigy Ag | Basische Carbonylverbindungen |
| DE3600594A1 (de) * | 1986-01-11 | 1987-07-16 | Bayer Ag | Methioninsubstituierte 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung |
| DE3601397A1 (de) * | 1986-01-18 | 1987-07-23 | Bayer Ag | Substituierte 1,4-dihydropyridin-3-carbonsaeurepiperazide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| DK114587A (da) * | 1986-03-12 | 1987-09-13 | Byk Gulden Lomberg Chem Fab | Monocycliske esterderivater |
| DE3617976A1 (de) * | 1986-05-28 | 1988-01-14 | Alter Sa | 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten |
| US4761420A (en) * | 1986-06-13 | 1988-08-02 | Laboratoires Syntex S.A. | Antihypertensive dihydropyridine derivatives |
| US4886819A (en) * | 1986-08-27 | 1989-12-12 | The Green Cross Corporation | Dihydropyridine derivatives and pharmaceutical composition thereof |
| JPH0688973B2 (ja) * | 1987-03-12 | 1994-11-09 | 京都薬品工業株式会社 | １，４−ジヒドロピリジン誘導体 |
| US5047543A (en) * | 1988-11-24 | 1991-09-10 | Taisho Pharmaceutical Co., Ltd. | 1,4-dihydropyridine derivatives |
| ATE200484T1 (de) * | 1992-08-31 | 2001-04-15 | Mercian Corp | Verfahren zur herstellung von optisch aktiven 1,4-dihydropyridinen |
| DE4233347A1 (de) * | 1992-10-05 | 1994-04-07 | Bayer Ag | Dihydropyridin-alkoxy- und -alkylamino-aroylester |
| DE4236707A1 (de) * | 1992-10-30 | 1994-05-05 | Bayer Ag | 4-Heterocyclyl substituierte Dihydropyridine |
| ES2096179T3 (es) * | 1992-10-30 | 1997-03-01 | Bayer Ag | Dihidropiridinas sustituidas en la posicion 4 con un heterociclilfenilo. |
| US6001857A (en) * | 1992-10-30 | 1999-12-14 | Bayer Aktiengesellschaft | Heterocyclyl substituted dihydropyridines |
| DE4342193A1 (de) * | 1993-12-10 | 1995-06-14 | Bayer Ag | Arylsubstituierte Alkoxycarbonyl-1,4-dihydropyridin-5-carbonsäureester |
| ATE220395T1 (de) * | 1994-08-29 | 2002-07-15 | Mercian Corp | 1,4-dihydropyridin-derivate |
| CN1338924A (zh) * | 1999-01-08 | 2002-03-06 | 艾米斯菲尔技术有限公司 | 聚合物输送剂和输送剂化合物 |
| RU2239432C2 (ru) * | 2000-04-11 | 2004-11-10 | Санкио Компани Лимитед, Убе Индастриз, Лтд. | Стабилизированная фармацевтическая композиция, содержащая блокатор кальция |
| TW200806648A (en) * | 2005-11-29 | 2008-02-01 | Sankyo Co | Acid addition salts of dihydropyridine derivatives |
| TW200736245A (en) * | 2005-11-29 | 2007-10-01 | Sankyo Co | Acid addition salts of optically active dihydropyridine derivatives |
| US9227978B2 (en) | 2013-03-15 | 2016-01-05 | Araxes Pharma Llc | Covalent inhibitors of Kras G12C |
| AU2014239542A1 (en) * | 2013-03-15 | 2015-10-01 | Araxes Pharma Llc | Covalent inhibitors of KRas G12C |
| JO3805B1 (ar) | 2013-10-10 | 2021-01-31 | Araxes Pharma Llc | مثبطات كراس جي12سي |
| CN105669532B (zh) * | 2014-12-03 | 2018-11-02 | 广州市恒诺康医药科技有限公司 | 尼莫地平水溶性衍生物及其制备方法和应用 |
| CN107849022A (zh) | 2015-04-10 | 2018-03-27 | 亚瑞克西斯制药公司 | 取代的喹唑啉化合物和其使用方法 |
| WO2016168540A1 (en) | 2015-04-15 | 2016-10-20 | Araxes Pharma Llc | Fused-tricyclic inhibitors of kras and methods of use thereof |
| US10144724B2 (en) | 2015-07-22 | 2018-12-04 | Araxes Pharma Llc | Substituted quinazoline compounds and methods of use thereof |
| US10689356B2 (en) | 2015-09-28 | 2020-06-23 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| US10875842B2 (en) | 2015-09-28 | 2020-12-29 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| EP3356359B1 (en) | 2015-09-28 | 2021-10-20 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| US10858343B2 (en) | 2015-09-28 | 2020-12-08 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| WO2017058805A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
| WO2017058915A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
| EP3356351A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| AU2016355433C1 (en) | 2015-11-16 | 2021-12-16 | Araxes Pharma Llc | 2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof |
| US10646488B2 (en) | 2016-07-13 | 2020-05-12 | Araxes Pharma Llc | Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof |
| JP2019529484A (ja) | 2016-09-29 | 2019-10-17 | アラクセス ファーマ エルエルシー | Ｋｒａｓ ｇ１２ｃ変異体タンパク質の阻害剤 |
| US10377743B2 (en) | 2016-10-07 | 2019-08-13 | Araxes Pharma Llc | Inhibitors of RAS and methods of use thereof |
| EP3573954A1 (en) | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | Fused bicyclic benzoheteroaromatic compounds and methods of use thereof |
| EP3573971A1 (en) | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer |
| US11358959B2 (en) | 2017-01-26 | 2022-06-14 | Araxes Pharma Llc | Benzothiophene and benzothiazole compounds and methods of use thereof |
| EP3573967A1 (en) | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | Fused hetero-hetero bicyclic compounds and methods of use thereof |
| US11136308B2 (en) | 2017-01-26 | 2021-10-05 | Araxes Pharma Llc | Substituted quinazoline and quinazolinone compounds and methods of use thereof |
| KR20200010306A (ko) | 2017-05-25 | 2020-01-30 | 아락세스 파마 엘엘씨 | Kras의 공유적 억제제 |
| WO2018218069A1 (en) | 2017-05-25 | 2018-11-29 | Araxes Pharma Llc | Quinazoline derivatives as modulators of mutant kras, hras or nras |
| US10736897B2 (en) | 2017-05-25 | 2020-08-11 | Araxes Pharma Llc | Compounds and methods of use thereof for treatment of cancer |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670824C3 (de) * | 1967-03-20 | 1978-08-03 | Bayer Ag, 5090 Leverkusen | 1,4-Dihydropyridin-33-dicarbonsäurealkylester |
| DE2117573C3 (de) * | 1971-04-10 | 1978-07-27 | Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von unsymmetrischen l,4-Dihydropyridin-3,5dicarbonsäureestern, sowie ihre Verwendung als Arzneimittel |
| DE2117571C3 (de) * | 1971-04-10 | 1979-10-11 | Bayer Ag, 5090 Leverkusen | Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
| US3996234A (en) * | 1972-04-18 | 1976-12-07 | Bayer Aktiengesellschaft | 1,4-Dihydropyridine carboxylic acid esters |
| DE2218644C3 (de) * | 1972-04-18 | 1982-08-19 | Bayer Ag, 5090 Leverkusen | Basische Ester von 1,4-Dihydropyridinen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
| DE2508181A1 (de) * | 1975-02-26 | 1976-09-09 | Bayer Ag | 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| FR2405937A1 (fr) * | 1977-10-14 | 1979-05-11 | Labaz | Nouveaux derives de dihydropyridine, leur procede de preparation et leur application |
| SE429652B (sv) * | 1978-06-30 | 1983-09-19 | Haessle Ab | 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester |
| DE2847236A1 (de) * | 1978-10-31 | 1980-05-14 | Bayer Ag | Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| US4258042A (en) * | 1980-04-11 | 1981-03-24 | Usv Pharmaceutical Corporation | Antihypertensive pyridines and compositions |
| DE3042769A1 (de) * | 1980-11-13 | 1982-06-09 | Bayer Ag, 5090 Leverkusen | C-3 verknuepfte 1,4-dihydropyridine, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung |
| NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
| DE3208628A1 (de) * | 1982-03-10 | 1983-09-22 | Bayer Ag, 5090 Leverkusen | Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| WO1983003249A1 (en) * | 1982-03-17 | 1983-09-29 | Yoshitomi Pharmaceutical | 1,4-dihydropyridine-3,5-dicarboxylate derivatives |
-
1982
- 1982-11-18 US US06/637,216 patent/US4656181A/en not_active Expired - Lifetime
-
1983
- 1983-11-18 JP JP58503515A patent/JPS60500255A/ja active Granted
- 1983-11-18 DE DE8383903371T patent/DE3381680D1/de not_active Expired - Lifetime
- 1983-11-18 EP EP83903371A patent/EP0126094B1/fr not_active Expired - Lifetime
- 1983-11-18 WO PCT/CH1983/000128 patent/WO1984002132A1/de active IP Right Grant
- 1983-11-23 IT IT23841/83A patent/IT1167269B/it active
- 1983-11-23 CA CA000441800A patent/CA1256872A/fr not_active Expired
- 1983-11-24 ES ES527776A patent/ES8706633A1/es not_active Expired
-
1985
- 1985-05-30 ES ES543655A patent/ES8603700A1/es not_active Expired
- 1985-05-30 ES ES543654A patent/ES8603699A1/es not_active Expired
- 1985-05-30 ES ES543652A patent/ES8604147A1/es not_active Expired
- 1985-05-30 ES ES543653A patent/ES8703139A1/es not_active Expired
-
1986
- 1986-06-30 US US06/880,148 patent/US4727066A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES8703139A1 (es) | 1987-02-16 |
| EP0126094A1 (fr) | 1984-11-28 |
| US4727066A (en) | 1988-02-23 |
| IT1167269B (it) | 1987-05-13 |
| JPS60500255A (ja) | 1985-02-28 |
| DE3381680D1 (de) | 1990-07-26 |
| ES8603699A1 (es) | 1986-01-16 |
| US4656181A (en) | 1987-04-07 |
| ES543655A0 (es) | 1986-01-16 |
| JPH0559906B2 (es) | 1993-09-01 |
| WO1984002132A1 (en) | 1984-06-07 |
| ES8603700A1 (es) | 1986-01-16 |
| EP0126094B1 (fr) | 1990-06-20 |
| ES543654A0 (es) | 1986-01-16 |
| ES8706633A1 (es) | 1987-07-16 |
| CA1256872A (fr) | 1989-07-04 |
| ES543653A0 (es) | 1987-02-16 |
| ES8604147A1 (es) | 1986-01-16 |
| ES527776A0 (es) | 1987-07-16 |
| IT8323841A0 (it) | 1983-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES543652A0 (es) | Procedimiento de obtencion de derivados 1,4-dihidropiridini-cos | |
| ES499299A0 (es) | Procedimiento de preparacion de derivados de la trimetoxi- 3,4,5 cinamoilpiperacina | |
| ES521865A0 (es) | Procedimiento de producir derivados oxazolicos. | |
| RO84099A (ro) | Procedeu pentru obtinerea 1,2,5-o0adiazol-2-o0izilor | |
| DE3371781D1 (de) | 1,4-methano-2-benzazepine derivatives | |
| ES536488A0 (es) | Procedimiento de obtencion de 6-metil-19-nor-pregna 4, 6 dieno 3, 20-dionas | |
| ES512397A0 (es) | "procedimiento para preparar derivados de nicotinoilbenzoguanamina". | |
| ES539074A0 (es) | Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos. | |
| ES516880A0 (es) | Procedimiento de preparar derivados de p-acilaminofenol. | |
| ES522653A0 (es) | Procedimiento de preparacion de derivados de piperacina. | |
| AR240934A1 (es) | Procedimiento para obtener derivados de acridanona" | |
| ES520201A0 (es) | Procedimiento para la obtencion de derivados de 1,4-dihidropiridina. | |
| FR2520366B1 (fr) | Derives de 23-o-acyl-23-demycinosyldesmycosine | |
| ES533691A0 (es) | Procedimiento de preparar 2,9-dihidrofuranos | |
| ES514167A0 (es) | "procedimiento de obtencion de benzhidrilpiperazinas". | |
| ES521598A0 (es) | Procedimiento de preparar derivados piridotienopiridacinicos. | |
| ES525995A0 (es) | Procedimiento de obtencion de piridopirimidinonas | |
| ES521720A0 (es) | Procedimiento de obtencion de nuevas carboxamidoguanidinas. | |
| ES523330A0 (es) | Procedimiento para la obtencion de derivados de bencilurea. | |
| ES529960A0 (es) | Procedimiento para la obtencion de alcoximinoalquilamino-1, 3, 5-triazinas | |
| ES508693A0 (es) | "procedimiento para la obtencion de derivados de aminoalkilfuranos". | |
| FI832262A0 (fi) | Foerfarande foer framstaellning av 1-alkyl- eller 1,4-dialkyl-1h-pyrrol-2-aettiksyraestrar | |
| DE3363710D1 (de) | 1,3,5-triacrylylhexahydro-s-triazine derivatives | |
| AR226749A1 (es) | Procedimiento de preparacion de derivados de 1,4-dioxido de 2-metilen-quinoxalina | |
| ES521588A0 (es) | Procedimiento de obtencion de nuevas n-ciano-formamidinas. |